# Acoustic Coordinated Reset (CR®) Neuromodulation for the Treatment of Chronic Tonal Tinnitus ("RESET Real Life")

> **NCT01435317** · PHASE4 · COMPLETED · sponsor: **ANM Adaptive Neuromodulation GmbH** · enrollment: 200 (actual)

## Conditions studied

- Tinnitus

## Interventions

- **DEVICE:** ANM T30 CR®-System

## Key facts

- **NCT ID:** NCT01435317
- **Lead sponsor:** ANM Adaptive Neuromodulation GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2013-06
- **Final completion:** 2014-07
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2014-07-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01435317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01435317, "Acoustic Coordinated Reset (CR®) Neuromodulation for the Treatment of Chronic Tonal Tinnitus ("RESET Real Life")". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01435317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*